%0 Journal Article
%B The Lancet Diabetes and Endocrinology
%D 2020
%P 582 - 593
%T Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
%V 8